Free Trial

CME Group Inc. $CME Shares Purchased by Vanguard Personalized Indexing Management LLC

CME Group logo with Finance background

Key Points

  • Vanguard Personalized Indexing Management LLC increased its stake in CME Group Inc. by 26.6% in the second quarter, bringing its total holdings to 45,755 shares valued at approximately $12.6 million.
  • Recent analyst ratings for CME Group show a mix of opinions, with seven ratings as Buy, seven as Hold, and two as Sell, indicating a consensus target price of $281.00.
  • CME Group declared a quarterly dividend of $1.25, resulting in an annualized dividend yield of 1.8% and a payout ratio of 48.40%.
  • Interested in CME Group? Here are five stocks we like better.

Vanguard Personalized Indexing Management LLC boosted its position in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 26.6% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 45,755 shares of the financial services provider's stock after acquiring an additional 9,602 shares during the period. Vanguard Personalized Indexing Management LLC's holdings in CME Group were worth $12,616,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Great Lakes Advisors LLC raised its position in CME Group by 2.3% in the 1st quarter. Great Lakes Advisors LLC now owns 1,661 shares of the financial services provider's stock valued at $441,000 after purchasing an additional 37 shares during the last quarter. Beaumont Financial Advisors LLC raised its position in CME Group by 2.0% in the 2nd quarter. Beaumont Financial Advisors LLC now owns 1,952 shares of the financial services provider's stock valued at $538,000 after purchasing an additional 38 shares during the last quarter. Trifecta Capital Advisors LLC raised its position in CME Group by 59.2% in the 2nd quarter. Trifecta Capital Advisors LLC now owns 113 shares of the financial services provider's stock valued at $31,000 after purchasing an additional 42 shares during the last quarter. OneAscent Financial Services LLC raised its position in CME Group by 4.0% in the 1st quarter. OneAscent Financial Services LLC now owns 1,106 shares of the financial services provider's stock valued at $293,000 after purchasing an additional 43 shares during the last quarter. Finally, Highline Wealth Partners LLC raised its position in CME Group by 84.3% in the 2nd quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider's stock valued at $26,000 after purchasing an additional 43 shares during the last quarter. Institutional investors and hedge funds own 87.75% of the company's stock.

Analysts Set New Price Targets

Several research firms recently commented on CME. Jefferies Financial Group reduced their price target on shares of CME Group from $313.00 to $304.00 and set a "buy" rating for the company in a research report on Friday. Morgan Stanley upped their price objective on shares of CME Group from $303.00 to $312.00 and gave the stock an "overweight" rating in a research report on Wednesday, October 1st. UBS Group cut their price objective on shares of CME Group from $305.00 to $285.00 and set a "neutral" rating for the company in a research report on Monday, September 8th. Wall Street Zen downgraded shares of CME Group from a "hold" rating to a "sell" rating in a research report on Sunday, July 13th. Finally, TD Cowen upped their price objective on shares of CME Group from $281.00 to $288.00 and gave the stock a "hold" rating in a research report on Wednesday, October 8th. Seven equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and two have assigned a Sell rating to the company's stock. According to data from MarketBeat, the stock currently has an average rating of "Hold" and a consensus target price of $281.00.

Check Out Our Latest Analysis on CME

Insider Activity at CME Group

In other news, insider Timothy Francis Mccourt sold 379 shares of the stock in a transaction dated Tuesday, September 16th. The shares were sold at an average price of $259.83, for a total value of $98,475.57. Following the completion of the transaction, the insider owned 9,508 shares in the company, valued at $2,470,463.64. This trade represents a 3.83% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, General Counsel Jonathan L. Marcus sold 392 shares of the stock in a transaction dated Thursday, September 18th. The shares were sold at an average price of $262.00, for a total transaction of $102,704.00. Following the completion of the transaction, the general counsel owned 7,851 shares of the company's stock, valued at $2,056,962. This represents a 4.76% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 13,043 shares of company stock worth $3,527,956. 0.30% of the stock is owned by company insiders.

CME Group Stock Performance

Shares of CME opened at $271.45 on Monday. The company has a 50-day simple moving average of $268.89 and a 200-day simple moving average of $271.29. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12. The company has a market capitalization of $97.83 billion, a PE ratio of 26.28, a P/E/G ratio of 5.72 and a beta of 0.41. CME Group Inc. has a 52-week low of $213.94 and a 52-week high of $290.79.

CME Group (NASDAQ:CME - Get Free Report) last announced its quarterly earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.91 by $0.05. The business had revenue of $1.69 billion during the quarter, compared to the consensus estimate of $1.68 billion. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The business's revenue was up 10.4% compared to the same quarter last year. During the same quarter last year, the firm posted $2.56 EPS. Equities research analysts predict that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, September 25th. Stockholders of record on Tuesday, September 9th were issued a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.8%. The ex-dividend date was Tuesday, September 9th. CME Group's dividend payout ratio (DPR) is currently 48.40%.

CME Group Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Recommended Stories

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in CME Group Right Now?

Before you consider CME Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.

While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.